507 related articles for article (PubMed ID: 21216540)
21. Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera™ PCV MH) under experimental conditions.
Park C; Jeong J; Choi K; Chae C
Vaccine; 2016 Jan; 34(2):270-275. PubMed ID: 26626212
[TBL] [Abstract][Full Text] [Related]
22. PCV2 vaccination induces IFN-γ/TNF-α co-producing T cells with a potential role in protection.
Koinig HC; Talker SC; Stadler M; Ladinig A; Graage R; Ritzmann M; Hennig-Pauka I; Gerner W; Saalmüller A
Vet Res; 2015 Mar; 46():20. PubMed ID: 25888899
[TBL] [Abstract][Full Text] [Related]
23. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.
Opriessnig T; O'Neill K; Gerber PF; de Castro AM; Gimenéz-Lirola LG; Beach NM; Zhou L; Meng XJ; Wang C; Halbur PG
Vaccine; 2013 Jan; 31(3):487-94. PubMed ID: 23174198
[TBL] [Abstract][Full Text] [Related]
24. Comparison of three commercial one-dose porcine circovirus type 2 (PCV2) vaccines in a herd with concurrent circulation of PCV2b and mutant PCV2b.
Jeong J; Park C; Choi K; Chae C
Vet Microbiol; 2015 May; 177(1-2):43-52. PubMed ID: 25790733
[TBL] [Abstract][Full Text] [Related]
25. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
[TBL] [Abstract][Full Text] [Related]
26. Effect of sow and piglet porcine circovirus type 2 (PCV2) vaccination on piglet mortality, viraemia, antibody titre and production parameters.
Fraile L; Sibila M; Nofrarías M; López-Jimenez R; Huerta E; Llorens A; López-Soria S; Pérez D; Segalés J
Vet Microbiol; 2012 Dec; 161(1-2):229-34. PubMed ID: 22858231
[TBL] [Abstract][Full Text] [Related]
27. Improvement of the Immunogenicity of Porcine Circovirus Type 2 DNA Vaccine by Recombinant ORF2 Gene and CpG Motifs.
Li J; Shi JL; Wu XY; Fu F; Yu J; Yuan XY; Peng Z; Cong XY; Xu SJ; Sun WB; Cheng KH; Du YJ; Wu JQ; Wang JB; Huang BH
Viral Immunol; 2015 Jun; 28(5):290-6. PubMed ID: 26046831
[TBL] [Abstract][Full Text] [Related]
28. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
Fenaux M; Opriessnig T; Halbur PG; Elvinger F; Meng XJ
J Virol; 2004 Jun; 78(12):6297-303. PubMed ID: 15163723
[TBL] [Abstract][Full Text] [Related]
29. Effect of Maternal Antibody Transfer on Antibody Dynamics and Control of Porcine Circovirus Type 2 Infection in Offspring.
Dvorak CMT; Payne BJ; Seate JL; Murtaugh MP
Viral Immunol; 2018; 31(1):40-46. PubMed ID: 28817375
[TBL] [Abstract][Full Text] [Related]
30. Comparative analyses of humoral and cell-mediated immune responses upon vaccination with different commercially available single-dose porcine circovirus type 2 vaccines.
Seo HW; Lee J; Han K; Park C; Chae C
Res Vet Sci; 2014 Aug; 97(1):38-42. PubMed ID: 24794246
[TBL] [Abstract][Full Text] [Related]
31. Porcine circovirus type 2 infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus vaccine.
Opriessnig T; McKeown NE; Harmon KL; Meng XJ; Halbur PG
Clin Vaccine Immunol; 2006 Aug; 13(8):923-9. PubMed ID: 16893993
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge.
Park KH; Oh T; Yang S; Cho H; Kang I; Chae C
Vet Microbiol; 2019 Apr; 231():87-92. PubMed ID: 30955830
[TBL] [Abstract][Full Text] [Related]
33. Comparison of effects of a single dose of MHYOSPHERE® PCV ID with three commercial porcine vaccine associations against Mycoplasma hyopneumoniae (Mhyo) and porcine circovirus type 2 (PCV2) on piglet growth during the nursery period under field conditions.
Puig A; Bernal I; Sabaté D; Ballarà I; Montané J; Nodar L; Angelats D; Jordà R
Vet Res Commun; 2022 Dec; 46(4):1167-1173. PubMed ID: 35829861
[TBL] [Abstract][Full Text] [Related]
34. Comparative effects of vaccination against porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) in a PCV2-PRRSV challenge model.
Park C; Oh Y; Seo HW; Han K; Chae C
Clin Vaccine Immunol; 2013 Mar; 20(3):369-76. PubMed ID: 23302743
[TBL] [Abstract][Full Text] [Related]
35. A live-attenuated chimeric porcine circovirus type 2 (PCV2) vaccine is transmitted to contact pigs but is not upregulated by concurrent infection with porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV) and is efficacious in a PCV2b-PRRSV-PPV challenge model.
Opriessnig T; Shen HG; Pal N; Ramamoorthy S; Huang YW; Lager KM; Beach NM; Halbur PG; Meng XJ
Clin Vaccine Immunol; 2011 Aug; 18(8):1261-8. PubMed ID: 21653745
[TBL] [Abstract][Full Text] [Related]
36. Comparison of sow and/or piglet vaccination of 3 commercial porcine circovirus type 2 (PCV2) single-dose vaccines on pigs under experimental PCV2 challenge.
Oh Y; Seo HW; Park C; Chae C
Vet Microbiol; 2014 Aug; 172(3-4):371-80. PubMed ID: 24970364
[TBL] [Abstract][Full Text] [Related]
37. Comparison of four commercial one-dose porcine circovirus type 2 (PCV2) vaccines administered to pigs challenged with PCV2 and porcine reproductive and respiratory syndrome virus at 17 weeks postvaccination to control porcine respiratory disease complex under Korean field conditions.
Park C; Seo HW; Han K; Chae C
Clin Vaccine Immunol; 2014 Mar; 21(3):399-406. PubMed ID: 24403524
[TBL] [Abstract][Full Text] [Related]
38. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2.
Horlen KP; Dritz SS; Nietfeld JC; Henry SC; Hesse RA; Oberst R; Hays M; Anderson J; Rowland RR
J Am Vet Med Assoc; 2008 Mar; 232(6):906-12. PubMed ID: 18341450
[TBL] [Abstract][Full Text] [Related]
39. Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2.
Opriessnig T; Patterson AR; Elsener J; Meng XJ; Halbur PG
Clin Vaccine Immunol; 2008 Mar; 15(3):397-401. PubMed ID: 18094109
[TBL] [Abstract][Full Text] [Related]
40. Comparative efficacy of three commercial PCV2 vaccines in conventionally reared pigs.
Lyoo K; Joo H; Caldwell B; Kim H; Davies PR; Torrison J
Vet J; 2011 Jul; 189(1):58-62. PubMed ID: 20691624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]